Senate holds third hearing on recent surge in older drug prices

AHA News Now

The Senate Special Committee on Aging today held the third in a series of hearings to investigate sudden and aggressive price spikes in older prescription drugs. Testifying at the hearing, Richard Fogel, M.D., chief clinical officer for Ascension Health’s St. Vincent health system in Indiana, said... read more

Topic: Advocacy and Public Policy
Tags: 340B, drug prices

AHASTAT blog: Reducing 340B is not the answer to curbing skyrocketing drug prices

AHA News Now

A recent proposal that calls for reducing the benefits of the 340B Drug Pricing Program to curb rapidly rising prescription drug costs is “misguided,” writes AHA Executive Vice President Tom Nickels in an AHASTAT blog post today. Responding to a recent opinion piece in the New England Journal of Medicine,... read more

Topic: Advocacy and Public Policy
Tag: 340B

Changing 340B is the wrong prescription for addressing skyrocketing pharmaceutical costs

Blog

The rapidly rising costs of prescription drugs is causing significant financial challenges for patients and their care providers.

Many groups, including the AHA, are evaluating options for addressing this important issue. However, one recent proposal, which is seriously misguided, would reduce a program... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, access, price, drug prices

CMS issues final rule for Medicaid drug rebates, reimbursement

AHA News Now

The Centers for Medicare & Medicaid Services yesterday published its long-awaited final rule implementing Affordable Care Act changes to the Medicaid Drug Rebate Program and Medicaid reimbursement for covered outpatient drugs. According to CMS, the rule creates a regulatory definition for Average... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, Medicaid, regulation

AHA critical of MedPAC's "misdirected" 340B payment proposal

AHA News

The AHA last week criticized as “misdirected” and a blow to patient care the Medicare Payment Assessment Commission’s (MedPAC) recommendation that Congress reduce Part B drug payment rates to hospitals participating in the 340B Drug Pricing Program.

At its Jan. 14 meeting, the commission voted 14 to 3 to... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program

MedPAC finalizes 2017 payment recommendations for hospital services

AHA News Now

The Medicare Payment Advisory Commission today recommended that Congress update payments for hospital inpatient and outpatient services in 2017 as outlined under current law, which would provide an estimated 1.65% increase. In addition, MedPAC voted to reduce Part B drug payment rates for hospitals... read more

Topic: Advocacy and Public Policy
Tags: 340B, Medicare

AHA urges MedPAC to withdraw 340B payment proposal

AHA News Now

The AHA today urged the Medicare Payment Advisory Commission to withdraw its draft recommendation to reduce Part B drug payment rates to hospitals participating in the 340B Drug Pricing Program. “This recommendation is outside of the scope of MedPAC’s mission, lacks a clear purpose and penalizes certain... read more

Topic: Advocacy and Public Policy
Tags: 340B, Medicare

Hospitals brief Congress on benefits of 340B program, concerns with HRSA guidance

AHA News Now

At an AHA-sponsored briefing today on Capitol Hill, hospital leaders shared with congressional staff the many benefits that the 340B Drug Pricing Program brings to vulnerable patients and urged Congress to preserve the program. “People within the communities that Trinity Health serves receive tremendous... read more

Topic: Advocacy and Public Policy
Tags: 340B, advocacy

Congress urged to continue commitment to rural hospitals

AHA News Now

In commemoration of National Rural Health Day, the AHA today expressed appreciation to members of the Senate Rural Health Caucus and House Rural Health Care Coalition for their ongoing commitment to America’s rural hospitals and the communities and patients they serve. The letters praise the lawmakers’... read more

Topic: Advocacy and Public Policy
Tags: 340B, physicians, readmissions, socioeconomic status, RACs, EHRs, Electronic Health Records, Medicare, rural, Critical Access Hospitals

Amid concerns of possible policy changes, hospitals brief Congress on 340B's benefits

AHA News

At an AHA-sponsored briefing Nov. 19 on Capitol Hill, hospital leaders urged Congress to protect the 340B Drug Pricing Program, and shared with congressional staff the benefits that the program brings to vulnerable patients.

“People within the communities that Trinity Health serves receive tremendous and... read more

Topics: Access and Coverage, Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, access

Keyword Search

Date